echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Drugs Articles > The total output value of Xi'an biopharmaceutical industry will reach 50 billion yuan in 2020.

    The total output value of Xi'an biopharmaceutical industry will reach 50 billion yuan in 2020.

    • Last Update: 2020-07-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    " "Pharmaceutical Network Market Analysis" In recent years, Xi'an Biopharmaceutical Industry has shown a large-scale development trend, forming a chemical and preparation production cluster represented by Libang Pharmaceuticals and Bandung Pharmaceuticals, a cluster of traditional Chinese medicine produced by Step Pharma and Jinhua Pharmaceuticals, a natural plant extraction production cluster represented by Yantian Bio and Jiayu Bio, a genetic detection cluster represented by The U.S. Gene, and a medical device production cluster represented by Tianlong Technology and Gold magnetic nano.2020, the total output value of Xi'an's biopharmaceutical industry is expected to reach 50 billion yuan.at present, Xi'an City has formed a biopharmaceutical industry development pattern based on chemical drugs, Chinese medicine, biological medicine, medical device industry, xixian new area, high-tech zone, open area and other development zones as the main carrier.brought together 2,758 biopharmaceutical production and research and development enterprises, including 141 national high-tech enterprises, 4 pharmaceutical industry top 100 enterprises, 2 listed enterprises, 8 new three-board listed enterprises.in these enterprises, including Shaanxi Pharmaceutical Group, Xi'an Yangsen, Libang Pharmaceuticals, Datang Pharmaceuticals and other large-scale biopharmaceutical backbone enterprises, but also some in the sub-sector sitcom stake in the new drug, Kanto Medical, Juzi bio, gold magnetic nano and other small and medium-sized biopharmaceutical enterprises.Xi'an High-tech Zone's biopharmaceutical industry has been one of the key development of strategic emerging industries, currently gathered more than 400 biopharmaceutical enterprises, and in these 400 pharmaceutical enterprises, 24 enterprises have sales of more than 100 million yuan.from the recent release of the first quarter of the high-tech zone data can be seen, in the industrial economy, biomedicine and semiconductor manufacturing, communications manufacturing, automobile manufacturing accounted for the high-tech zone industry", accounting for up to 68%., the biopharmaceutical industry accounted for 11%.it is understood that the next step, the high-tech zone will continue to adhere to the industrial zone, industrial demonstration development model, and strive to become a bio-pharmaceutical industry by 2025, such as 4 000 billion levels of innovative industrial clusters.policy has also given strong support to Xi'an biopharmaceutical industry.for example, in December 2019, Xi'an City issued the "Opinion" proposed that, based on chemical drugs, traditional Chinese medicine, biological drugs, medical deviceindustry, 3D printing, optical equipment, regenerative medicine, gene sequencing, peptides and proteins and other high-precision technology as the lead, around the "stronger modern Chinese medicine, do optimization medicine, make large Biopharmaceuticals, refined medical devices, professional health tourism "five key areas, the implementation of "industry foundation cultivation, industrial innovation transformation, industrial cooperation promotion, industrial digital transformation" four major projects, promote the stock upgrading transformation and incremental cultivation breakthrough, to build the national biopharmaceutical industry (high-end medical equipment) innovation base and serve the "Belt and Road" health tourism destination., Xi'an city has also issued a series of support policies for the biopharmaceutical industry, such as the Action Plan for the Development of the Biopharmaceutical Industry Cluster in Xi'an City (2020-2022), and established a 100 billion yuan Xi'an Science and Technology Industry Development Fund to attract more social capital and financial institutions to invest in the hard science and technology industry, including the biopharmaceutical industry, through market-oriented forces to further promote the development of biopharmaceutical industry, attract more enterprises and talents from the bio-pharmaceutical industry.industry believes that in this context, Xi'an biopharmaceutical industry is expected to rely on a good foundation for development, strong innovation ability, excellent business environment and other growing, the future development potential is huge..
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.